Carcinoma of the breast. Immune behaviour. Immunostimulation by fraction P40
Reynier, J.; Bazin, J.C.; Bizzini, B.; Gandrille, C.; Guettier, C.; Henocq, E.; Hollmann, K.; Mogenet, M.; Pompidou, A.; Santus, J.P.; Verley, J.M.; Villet, R.
Chirurgie; Memoires de l'Academie de Chirurgie 106(1): 48-55
1980
ISSN/ISBN: 0001-4001 PMID: 7379633 Document Number: 160022
Document emailed within 1 workday
Related Documents
Santus, J.P.; Henocq, E.; Bizzini, B.; Bazin, J.C.; Mogenet, M.; Villet, R.; Reynier, J. 1979: Breast cancer: a dynamic approach of cellular immunity and immunostimulation with an immunoadjuvant: P40 fraction Pathologie-Biologie 27(7): 395-401Charpin, C.; Andrac, L.; Vacheret, H.; Habib, M.C.; Devictor, B.; Lavaut, M.N.; Toga, M. 1988: Multiparametric evaluation (SAMBA) of growth fraction (monoclonal Ki67) in breast carcinoma tissue sections Cancer Research 48(15): 4368-4374
Frost, A.R.; Karcher, D.S.; Terahata, S.; Siegel, R.S.; Silverberg, S.G. 1996: DNA analysis and S-phase fraction determination by flow cytometric analysis of infiltrating lobular carcinoma of the breast Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 9(9): 930-937
Armellino, F.; Malanetto, C.; Girotto, M.; Rossetto, P.; Francisco, G. 1986: Evaluation of the immune status in patients with breast carcinoma Minerva Ginecologica 38(10): 811-814
Meyer, J.S.; Lee, J.Y. 1980: Relationships of S-phase fraction of breast carcinoma in relapse to duration of remission, estrogen receptor content, therapeutic responsiveness, and duration of survival Cancer Research 40(6): 1890-1896
Springer, G.F.; Desai, P.R.; Fry, W.A.; Goodale, R.L.; Shearen, J.G.; Scanlon, E.F. 1983: T antigen, a tumor marker against which breast, lung and pancreas carcinoma patients mount immune responses Cancer Detection and Prevention 6(1-2): 111-118
Ludwig, C.; Hartmann, D.; Landmann, R.; Wesp, M.; Rosenfelder, G.; Stucki, D.; Buser, M.; Obrecht, J.P. 1983: Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis Schweizerische Medizinische Wochenschrift 113(50): 1908-1911
Holder, W.D.; Wells, S.A. 1983: Antibody reacting with the murine mammary tumor virus in the serum of patients with breast carcinoma: a possible serological detection method for breast carcinoma Cancer Research 43(1): 239-244
Fleming, J.; Sheridan, B.; Atkinson, L.; Scott, G. 1970: Carcinoma of the breast: St. Vincent's Hospital series, 1954-1965. The effects of childbearing on carcinoma of the breast Medical Journal of Australia 1(25): 1252-1256
Meiss, L.; Djandji, V.; Raute, M.; Kühn, W. 1974: Therapy of breast carcinoma. Surgical, radiologic and hormonal treatment of a patient with breast carcinoma metastases. Clinical course with regard to pre-terminal immunoglobulin and complement changes Fortschritte der Medizin 92(14): 615-616
Brachetti, A.K.; Limburg, H. 1977: Ancillary chemotherapy in the primary treatment of carcinoma of the breast. on the growth pattern of carcinoma of the breast and the establishment of a new concept in treatment Geburtshilfe und Frauenheilkunde 37(2): 109-114
Jansen, H.M.; Esselink, M.T.; Orie, N.G.; The, T.H. 1979: Cell-mediated immune response in patients with bronchial carcinoma. Relation between clinical parameters and various immunological tests for immune status investigation Netherlands Journal of Medicine 22(1): 1-9
Pagani, A.; Iandolo, M. 2008: Invasive breast carcinoma with features of neuroendocrine carcinoma and carcinoma with osteoclastic cells: fine-needle aspiration cytology and histology of two cases Pathologica 100(3): 176-180
Messina, G.; Lissoni, P.; Brivio, F.; Rovelli, F.; Fumagalli, L.; Bartolacelli, E.; Mazza, U.; Colombo, E.; Bertoglio, A. 2008: A study of surgical psychoncology in breast cancer: perioperative variation of prolactin serum levels in women with operable breast cancer in relation to their maternal psychological behaviour In Vivo 22(6): 845-848
Papermaster, B.W.; Holtermann, O.A.; Rosner, D.; Klein, E.; Dao, T. 1974: Regressions produced in breast cancer lesions by a lymphokine fraction from a human lymphoid cell line Research Communications in Chemical Pathology and Pharmacology 8(2): 413-416
Charpin, C.; Habib, M.C.; Piana, L.; Rampal, M.; Andrac, L.; Vacheret, H.; Martini, P.; Perez-Castillo, M.; Lavaut, M.N.; Toga, M. 1989: Growth fraction (Ki67), ploidy balance and proliferation index in tumors of the urogenital tract and breast Annales de Pathologie 9(5): 331-339
Idova, G.V.; Al'perina, E.L.; Gevorgian, M.M.; Zhukova, E.N.; Kulikov, A.V.; Iur'ev, D.V. 2012: T-lymphocyte subpopulations and immune response in mice of the ASC strain with depressive-like behaviour Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova 98(2): 194-201
Wagner, T.; Adler, A.; Kubista, E. 1993: S-phase fraction and proportion of cells with high DNA content as prognostic factors of lymph node negative breast cancer Wiener Klinische Wochenschrift 105(24): 712-714
Vucković-Dekić, L.; Susnjar, S.; Stanojević-Bakić, N.; Rajner, L. 1994: Immunomodulating effect of thymus protein fraction on disorders of general immunity in patients with lung carcinoma Glas. Srpska Akademija Nauka i Umetnosti. Odeljenje Medicinskih Nauka 44: 63-70
Hahn, K.A.; Bravo, L.; Avenell, J.S. 1994: Feline breast carcinoma as a pathologic and therapeutic model for human breast cancer In Vivo 8(5): 825-828